Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Mazurek, Sybille·2011·The International Journal of Biochemistry & Cell Biology
Cited by (707)
Items 701–707 of 707
- BindingDB Entry 50034384: 2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.BindingDB · 2012 · UC San Diego
- BindingDB Entry 50016842: A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.BindingDB · 2023 · UC San Diego
- BindingDB Entry 50003593: Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents.BindingDB · 2024 · UC San Diego
- BindingDB Entry 50002955: The search for pyruvate kinase-R activators; from a HTS screening hit via an impurity to the discovery of a lead series.BindingDB · 2026 · UC San Diego
- BindingDB Entry 50043019: Discovery of 2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as novel PKM2 activators.BindingDB · 2014 · UC San Diego
- Role of stromal fibroblasts in prostate carcinoma progression and metabolic reprogramming of cancer cellsAlberto Marini · 2014 · UnissResearch (Università degli Studi di Sassari)
- Metabolic Adaptation in Reprogrammed Cancer CellsKevin M. Marks, Charles K.-H. Kung · 2014 · Cancer drug discovery and develogment/Cancer drug discovery and development